Literature DB >> 25505073

The progressive adaptation of a georgian isolate of African swine fever virus to vero cells leads to a gradual attenuation of virulence in swine corresponding to major modifications of the viral genome.

Peter W Krug1, Lauren G Holinka1, Vivian O'Donnell2, Bo Reese3, Brenton Sanford1, Ignacio Fernandez-Sainz2, Douglas P Gladue2, Jonathan Arzt1, Luis Rodriguez1, Guillermo R Risatti4, Manuel V Borca5.   

Abstract

UNLABELLED: African swine fever virus (ASFV) causes a contagious and often lethal disease of feral and domestic swine. Experimental vaccines derived from naturally occurring, genetically modified, or cell culture-adapted ASFV have been evaluated, but no commercial vaccine is available to control African swine fever (ASF). We report here the genotypic and phenotypic analysis of viruses obtained at different passages during the process of adaptation of a virulent ASFV field isolate from the Republic of Georgia (ASFV-G) to grow in cultured cell lines. ASFV-G was successively passaged 110 times in Vero cells. Viruses obtained at passages 30, 60, 80, and 110 were evaluated in vitro for the ability to replicate in Vero cells and primary swine macrophages cultures and in vivo for assessing virulence in swine. Replication of ASFV-G in Vero cells increased with successive passages, corresponding to a decreased replication in primary swine macrophages cultures. In vivo, progressive loss of virus virulence was observed with increased passages in Vero cells, and complete attenuation of ASFV-G was observed at passage 110. Infection of swine with the fully attenuated virus did not confer protection against challenge with virulent parental ASFV-G. Full-length sequence analysis of each of these viruses revealed significant deletions that gradually accumulated in specific areas at the right and left variable ends of the genome. Mutations that result in amino acid substitutions and frameshift mutations were also observed, though in a rather limited number of genes. The potential importance of these genetic changes in virus adaptation/attenuation is discussed. IMPORTANCE: The main problem in controlling ASF is the lack of vaccines. Attempts to produce vaccines by adaptation of ASFV to cultured cell lines have been made. These attempts led to the production of attenuated viruses that conferred only homologous protection. Specifics regarding adaptation of these isolates to cell cultures have been insufficiently described. Details like the numbers of passages required to obtain attenuated viruses, genetic modifications introduced into the virus genomes along passages, and the extent of attenuation and induced protective efficacy are not readily available. In this study, we assessed the changes that lead to decreased growth in swine macrophages and to attenuation in swine. Loss of virulence, probably associated with limited replication in vivo, may lead to the lack of protective immunity in swine observed after challenge. This report provides valuable information that can be used to further the understanding of ASFV gene function, virus attenuation, and protection against infection.
Copyright © 2015, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25505073      PMCID: PMC4338881          DOI: 10.1128/JVI.03250-14

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  25 in total

1.  A noninverting genome of a viable herpes simplex virus 1: presence of head-to-tail linkages in packaged genomes and requirements for circularization after infection.

Authors:  K L Poffenberger; B Roizman
Journal:  J Virol       Date:  1985-02       Impact factor: 5.103

2.  An African swine fever virus ERV1-ALR homologue, 9GL, affects virion maturation and viral growth in macrophages and viral virulence in swine.

Authors:  T Lewis; L Zsak; T G Burrage; Z Lu; G F Kutish; J G Neilan; D L Rock
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

3.  Novel swine virulence determinant in the left variable region of the African swine fever virus genome.

Authors:  J G Neilan; L Zsak; Z Lu; G F Kutish; C L Afonso; D L Rock
Journal:  J Virol       Date:  2002-04       Impact factor: 5.103

4.  Titration of African swine fever (ASF) virus.

Authors:  L Enjuanes; A L Carrascosa; M A Moreno; E Viñuela
Journal:  J Gen Virol       Date:  1976-09       Impact factor: 3.891

Review 5.  African swine fever virus replication and genomics.

Authors:  Linda K Dixon; David A G Chapman; Christopher L Netherton; Chris Upton
Journal:  Virus Res       Date:  2012-11-08       Impact factor: 3.303

6.  Analysis of the complete nucleotide sequence of African swine fever virus.

Authors:  R J Yáñez; J M Rodríguez; M L Nogal; L Yuste; C Enríquez; J F Rodriguez; E Viñuela
Journal:  Virology       Date:  1995-04-01       Impact factor: 3.616

7.  Characterization of pathogenic and non-pathogenic African swine fever virus isolates from Ornithodoros erraticus inhabiting pig premises in Portugal.

Authors:  F S Boinas; G H Hutchings; L K Dixon; P J Wilkinson
Journal:  J Gen Virol       Date:  2004-08       Impact factor: 3.891

8.  African swine fever virus multigene family 360 genes affect virus replication and generalization of infection in Ornithodoros porcinus ticks.

Authors:  T G Burrage; Z Lu; J G Neilan; D L Rock; L Zsak
Journal:  J Virol       Date:  2004-03       Impact factor: 5.103

9.  African swine fever virus multigene family 360 and 530 genes affect host interferon response.

Authors:  C L Afonso; M E Piccone; K M Zaffuto; J Neilan; G F Kutish; Z Lu; C A Balinsky; T R Gibb; T J Bean; L Zsak; D L Rock
Journal:  J Virol       Date:  2004-02       Impact factor: 5.103

10.  Neutralization of African swine fever virus by sera from African swine fever-resistant pigs.

Authors:  F Ruiz Gonzalvo; C Caballero; J Martinez; M E Carnero
Journal:  Am J Vet Res       Date:  1986-08       Impact factor: 1.156

View more
  58 in total

1.  African Swine Fever Virus Georgia Isolate Harboring Deletions of MGF360 and MGF505 Genes Is Attenuated in Swine and Confers Protection against Challenge with Virulent Parental Virus.

Authors:  Vivian O'Donnell; Lauren G Holinka; Douglas P Gladue; Brenton Sanford; Peter W Krug; Xiqiang Lu; Jonathan Arzt; Bo Reese; Consuelo Carrillo; Guillermo R Risatti; Manuel V Borca
Journal:  J Virol       Date:  2015-03-25       Impact factor: 5.103

2.  Simultaneous Deletion of the 9GL and UK Genes from the African Swine Fever Virus Georgia 2007 Isolate Offers Increased Safety and Protection against Homologous Challenge.

Authors:  Vivian O'Donnell; Guillermo R Risatti; Lauren G Holinka; Peter W Krug; Jolene Carlson; Lauro Velazquez-Salinas; Paul A Azzinaro; Douglas P Gladue; Manuel V Borca
Journal:  J Virol       Date:  2016-12-16       Impact factor: 5.103

3.  African Swine Fever Virus Georgia 2007 with a Deletion of Virulence-Associated Gene 9GL (B119L), when Administered at Low Doses, Leads to Virus Attenuation in Swine and Induces an Effective Protection against Homologous Challenge.

Authors:  Vivian O'Donnell; Lauren G Holinka; Peter W Krug; Douglas P Gladue; Jolene Carlson; Brenton Sanford; Marialexia Alfano; Edward Kramer; Zhiqiang Lu; Jonathan Arzt; Bo Reese; Consuelo Carrillo; Guillermo R Risatti; Manuel V Borca
Journal:  J Virol       Date:  2015-06-10       Impact factor: 5.103

4.  Deletion of the H108R Gene Reduces Virulence of the Pandemic Eurasia Strain of African Swine Fever Virus with Surviving Animals Being Protected against Virulent Challenge.

Authors:  Elizabeth Vuono; Elizabeth Ramirez-Medina; Ediane Silva; Ayushi Rai; Sarah Pruitt; Nallely Espinoza; Alyssa Valladares; Lauro Velazquez-Salinas; Douglas P Gladue; Manuel V Borca
Journal:  J Virol       Date:  2022-07-06       Impact factor: 6.549

5.  Evaluation of the Deletion of MGF110-5L-6L on Swine Virulence from the Pandemic Strain of African Swine Fever Virus and Use as a DIVA Marker in Vaccine Candidate ASFV-G-ΔI177L.

Authors:  Elizabeth Ramirez-Medina; Elizabeth Vuono; Ediane Silva; Ayushi Rai; Alyssa Valladares; Sarah Pruitt; Nallely Espinoza; Lauro Velazquez-Salinas; Manuel V Borca; Douglas P Gladue
Journal:  J Virol       Date:  2022-07-11       Impact factor: 6.549

Review 6.  Attenuated African swine fever virus through serial passaging of viruses in cell culture: a brief review on the knowledge gathered during 60 years of research.

Authors:  Xiaoyue Zhang; Zhenzhong Wang; Shengqiang Ge; Yuanyuan Zuo; Haodong Lu; Yan Lv; Naijun Han; Yumei Cai; Xiaodong Wu; Zhiliang Wang
Journal:  Virus Genes       Date:  2022-10-14       Impact factor: 2.198

7.  Development of optimized protocol for culturing African swine fever virus field isolates in MA104 cells.

Authors:  Hyeok-Il Kwon; Duy Tien Do; Hung Van Vo; Seung-Chul Lee; Min Ho Kim; Dung Thi Thuy Nguyen; Tan Minh Tran; Quang Tin Vinh Le; Tram Thi Ngoc Ngo; Nam Minh Nguyen; Joo Young Lee; Toan Tat Nguyen
Journal:  Can J Vet Res       Date:  2022-10       Impact factor: 0.897

8.  Purification of African Swine Fever Virus.

Authors:  Gareth L Shimmon; Pranav N M Shah; Elizabeth Fry; David I Stuart; Pippa Hawes; Christopher L Netherton
Journal:  Methods Mol Biol       Date:  2022

9.  A Cell Culture-Adapted Vaccine Virus against the Current African Swine Fever Virus Pandemic Strain.

Authors:  M V Borca; A Rai; E Ramirez-Medina; E Silva; L Velazquez-Salinas; E Vuono; S Pruitt; N Espinoza; D P Gladue
Journal:  J Virol       Date:  2021-06-24       Impact factor: 5.103

10.  African Swine Fever Virus MGF-110-9L-deficient Mutant Has Attenuated Virulence in Pigs.

Authors:  Dan Li; Yinguang Liu; Xiaolan Qi; Yuan Wen; Pan Li; Zhao Ma; Yongjie Liu; Haixue Zheng; Zhijie Liu
Journal:  Virol Sin       Date:  2021-03-10       Impact factor: 4.327

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.